Trial intelligence / Profile preview

Adalimumab for adhesive capsulitis (frozen shoulder)

2006-005426-23Phase 2Terminated

Sponsor
Pierre Schydlowsky
Start
Nov 2006
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 2 trial of adalimumab in adhesive capsulitis (AC) (2 arms), sponsored by Pierre Schydlowsky. Primary endpoints: 50% improvement in passive motion and Safety. Started Nov 2006; status: terminated.

02

Drugs

03

Conditions

adhesive capsulitis (AC)

Beyond the preview

Go deeper on 2006-005426-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005426-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call